Pembrolizumab for the Treatment of Relapsed and Refractory Classical Hodgkin Lymphoma After Autologous Transplant and in Transplant-Naïve Patients.
Halahleh K, Al Sawajneh S, Saleh Y, Shahin O, Abufara A, Ma'koseh M, Abdel-Razeq R, Barakat F, Abdelkhaleq H, Al-Hassan N, Atiyyat R, Al-Faker N, Omari Z, Ghatasheh H, Jaradat I, Muradi I, Iyad S, Bazarbachi A.
Halahleh K, et al.
Clin Lymphoma Myeloma Leuk. 2022 Aug;22(8):589-595. doi: 10.1016/j.clml.2022.02.009. Epub 2022 Mar 4.
Clin Lymphoma Myeloma Leuk. 2022.
PMID: 35490153